Congresss booth at the European Academy of Allergy and Clinical Immunology Congress 2023.

Orladeyo® is the first and only preventive treatment for hereditary angioedema (HAE), a rare condition that causes unpredictable, life-threatening swelling. By reducing attack frequency, it helps patients regain control and live without constant fear.

We took their simplistic campaign featuring a hand holding a single small capsule and turned it into an interactive experience centered around our message to healthcare professionals: "The possibilities are in your hands with Orladeyo®."

Using replica Orladeyo® capsules as tokens, attendees could power activations that symbolized the real-life impact of the treatment, creating a deeper, more emotional connection to the brand.

Orladeyo® EAACI Congress

Previous
Previous

DDB Digital Strategy